Description
SkinFill BLUE Exosome Technology 1 × 2 mL
SkinFill™ BLUE Exosome Technology is an injectable medical-aesthetic skin revitalisation device developed by Promoitalia for skin quality improvement, hydration, and tissue regeneration support. The formulation combines hyaluronic acid with exosome-based technology, designed to support intercellular communication and improve the biological environment of the skin. SkinFill BLUE is indicated for aesthetic protocols focused on skin texture, elasticity, and overall dermal condition, rather than volumetric correction.
The product is designed for superficial to mid-dermal application, supporting hydration and promoting a favourable environment for skin renewal. As part of the SkinFill range, SkinFill BLUE Exosome focuses on revitalisation and conditioning of the skin, making it suitable for patients seeking improvement in skin quality rather than contour alteration.
What SkinFill™ BLUE Is Similar To
SkinFill BLUE can be regarded alongside other skin booster and biorevitalisation injectables that aim to enhance skin quality through hydration and biological stimulation rather than structural filling. Products in this category are commonly used for preventive ageing protocols and regenerative-focused aesthetic treatments.
Unlike traditional dermal fillers, Skin Fill BLUE does not aim to restore volume or reshape facial contours. Instead, it is positioned within the growing category of exosome-supported skin revitalisation treatments, where the emphasis is placed on improving the dermal environment. Differences in formulation, sourcing, and regulatory classification mean products are not interchangeable. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer documentation, SkinFill BLUE Exosome Technology is indicated for skin revitalisation and quality improvement.
Treatment areas may include:
Face • Neck • Décolletage • Hands
Treatment selection should be based on practitioner assessment and patient skin condition.
Usage / Administration (IFU-only)
Injection depth: Superficial to mid-dermal layer.
Volume per point / injection site: Not provided by manufacturer.
Needle or device specification: Not provided by manufacturer.
Frequency / number of sessions: Not provided by manufacturer.
Professional-use disclaimer: Administered only by qualified medical professionals under aseptic conditions.
If any parameter is omitted in the official IFU, it is marked as “not provided by manufacturer.”
Ingredient List
Hyaluronic acid (concentration not specified by manufacturer)
Exosome-based components (exact source and concentration not publicly disclosed)
Physiological buffer solution
Lidocaine: Not provided by manufacturer.
Additional excipients as per IFU; trace components not disclosed.
Presentation & Longevity
Presentation: 1 × 2 mL pre-filled sterile syringe
Shelf-life: Not specified in public documentation; refer to packaging for expiry date.
Longevity (treatment duration): Improvements in skin quality are typically progressive and temporary, with maintenance treatments required depending on patient factors and protocol.
→ SkinFill BLUE before and after results vary and depend on skin condition, treatment plan, and practitioner technique.
Safety Notes / Contraindications
Use is contraindicated in patients with known hypersensitivity to any component of the product.
Avoid use in patients with active skin infection, inflammation, or compromised tissue at the injection site until resolved.
Do not inject intravascularly or into unintended tissue layers.
Single use only; do not reuse the syringe; ensure packaging is intact and within expiry.
Regulatory Status
CE-marked medical device in Europe.
UKCA status: verify via IFU or authorised distributor.
Regulatory classification of exosome-based components may vary by jurisdiction; verify on the product packaging or manufacturer’s IFU.
FAQ
1. What is SkinFill™ BLUE Exosome Technology?
SkinFill BLUE is an injectable skin revitalisation device combining hyaluronic acid with exosome-based technology to support skin hydration and quality improvement.
2. Is SkinFill BLUE a dermal filler?
No. SkinFill BLUE Exosome is not intended for volumisation or contour correction. It is designed for skin quality enhancement and revitalisation.
3. What are exosomes used for in aesthetic treatments?
In aesthetics, exosomes are used to support intercellular communication and promote a favourable skin environment. Their role is supportive rather than structural.
4. How long do SkinFill BLUE results last?
Results vary by patient and protocol. As a skin booster, effects are temporary and may require repeated sessions to maintain outcomes.
5. What safety considerations should practitioners keep in mind?
Practitioners should follow strict aseptic technique, confirm product authenticity, and ensure patient suitability, particularly when using regenerative-focused aesthetic devices.
